Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3367
Actual shortage: 219 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3138 (93%)

Discontinuation Reports

365
To be discontinued: 24 (7%)
Discontinued: 341 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

68 (28%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2022-02-04 2022-04-01 154168
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2018-01-31 2018-07-03 37717
APO-AMLODIPINE-ATORVASTATIN 5MG 10MG TABLET Resolved 2018-02-01 2018-07-03 37945
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2019-02-13 2019-04-22 75608
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2019-02-13 2019-04-22 75641
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2021-01-29 2021-05-26 132703
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2017-06-08 2017-08-08 12278
APO-AMLODIPINE-ATORVASTATIN 5MG 20MG TABLET Resolved 2017-07-11 2017-08-08 15420
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2017-08-14 2017-10-24 19213
APO-AMOXI 500MG CAPSULE Resolved 2024-12-05 2025-01-03 244926
APO-AMOXI 250MG POWDER FOR SUSPENSION Actual shortage 2025-05-08 2025-05-08 256914
APO-AMOXI 125MG POWDER FOR SUSPENSION Resolved 2020-11-04 2021-01-29 127751
APO-AMOXI 250MG POWDER FOR SUSPENSION Resolved 2022-06-17 2024-02-14 162918
APO-AMOXI 125MG POWDER FOR SUSPENSION Resolved 2022-08-12 2024-02-14 166621
APO-AMOXI 500MG CAPSULE Resolved 2022-11-27 2023-01-06 175904
APO-AMOXI 250MG CAPSULE Resolved 2022-12-05 2023-04-14 177129
APO-AMOXI 500MG CAPSULE Resolved 2019-10-23 2019-11-05 97034
APO-AMOXI 250MG POWDER FOR SUSPENSION Resolved 2020-01-08 2020-07-30 102528
APO-AMOXI 125MG POWDER FOR SUSPENSION Resolved 2020-03-04 2020-06-24 107690
APO-AMOXI 125MG POWDER FOR SUSPENSION Resolved 2020-07-08 2020-07-24 119693

Showing 321 to 340 of 3367

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-HYDROXYQUINE 200MG TABLET Discontinued 2018-09-07 2018-10-05 60524
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557

Showing 181 to 200 of 365